News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

Sample Collection Study for the CellMax Life Circulating Tumor Cell and Circulating Tumor DNA Platforms for the Early Detection of Colorectal Cancer and Adenomas

Study Status:

Open for enrollment

Contact Information:

(956) 362-2384

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The development of blood tests requires the collection of clinically defined biological specimens to evaluate the specificity, sensitivity, and clinical utility of the assay. Under this collection protocol, specimens will be obtained from patients with a diagnosis of colorectal cancer/advanced adenoma or undergoing a colonoscopy and meeting the criteria outlined within this protocol. The evaluation of these collected specimens will help expedite the development of future assays. These assays could someday result in significant improvements to early detection and/or treatment of various clinical diseases, including colorectal cancer (CRC).

Information: 

Principal Investigator
Dr. Murthy Badiga
Co-PI
Odalys Salinas
Sponsor
CELLMAX
Type of Trial
Interventional
© 2024 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram